Oral formats remove the injection barrier
The use of prazosin, an 1-adrenergic receptor blocker, showed that the ability of GLP-1RAs to reduce TNF- in plasma was disrupted, signifying the vital role of 1-adrenergic receptors in the anti-inflammatory action of GLP-1RAs
What conditions can be treated with GLP-1 therapy
You may be a candidate for facial fat transfer if you have: Hollowed cheeks, temples, or under-eyes after weight loss Deepened facial folds or sagging skin Adequate donor fat for transfer Realistic expectations for subtle, natural improvement Our Approach: Conservative and Personalized Dr
*Correspondence: Jun Xu, [email protected] This article was submitted to Endocrinology of Aging, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Nat Med 2024;30:205866